AFYX Therapeutics (private company)

AFYX Therapeutics, formerly known as Dermtreat, is a topical drug delivery company changing the way mucosal diseases are treated and developing a pipeline of targeted treatments for conditions that currently lack approved therapy options.

Companies with similar profile to AFYX Therapeutics:

Company	Criteria
Forendo Pharma 66%	Similar verticals: Health services, Pharma Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
NMD Pharma 66%	Similar verticals: Biotech, Health services, Pharma Similar business models: B2B At least one vc investor: Lundbeckfond Ventures, Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Galecto Biotech 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
BoneSupport 56%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Lundbeckfond Ventures Total raised in a similar range: 10M+ USD
MinervaX 56%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD
AMRA 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Snipr Biome 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Lundbeckfond Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Aprea Therapeutics 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
ITBMed 54%	Similar verticals: Biotech, Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Alvotech 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
OxThera 54%	Similar verticals: Biotech, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Asarina Pharma 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Mobidiag 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Oncoinvent 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Merozyne Therapeutics 46%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds
Antag Therapeutics 46%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds
MetGen 45%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sofinnova Partners Minim one investor from outside Scandinavia: Yes
Biosyntia 45%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Novo Seeds, Sofinnova Partners Minim one investor from outside Scandinavia: Yes
IO Biotech 45%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Lundbeckfond Ventures Total raised in a similar range: 10M+ USD
BioPhero 45%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Novo Seeds Minim one investor from outside Scandinavia: Yes